Macrogen, Inc. (KOSDAQ:038290)
16,250
-650 (-3.85%)
Apr 29, 2026, 11:40 AM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 183.22 billion as of April 28, 2026. Its market cap has increased by 6.83% in one year.
Market Cap
183.22B
Enterprise Value
248.71B
Revenue
195.27B
Ranking
n/a
PE Ratio
90.37
Stock Price
16,250.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has increased from 148.29B to 183.22B, an increase of 23.56%. That is a compound annual growth rate of 0.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 184.85B | 1.07% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Therapeutics | 321.66B |
| Bioneer | 283.14B |
| EASY BIO,Inc. | 263.99B |
| Genexine | 261.05B |
| JETEMA, | 260.84B |
| MedPacto | 185.09B |
| Vaxcell-Bio Therapeutics | 182.57B |
| ENCell | 181.64B |